Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Profound Medical (PROF) Gross Margin (2023 - 2025)

Historic Gross Margin for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to 74.32%.

  • Profound Medical's Gross Margin rose 111900.0% to 74.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 72.49%, marking a year-over-year increase of 130100.0%. This contributed to the annual value of 65.89% for FY2024, which is 59900.0% up from last year.
  • As of Q3 2025, Profound Medical's Gross Margin stood at 74.32%, which was up 111900.0% from 73.18% recorded in Q2 2025.
  • Profound Medical's Gross Margin's 5-year high stood at 74.32% during Q3 2025, with a 5-year trough of 49.23% in Q4 2023.
  • Moreover, its 3-year median value for Gross Margin was 65.22% (2023), whereas its average is 65.22%.
  • Over the last 5 years, Profound Medical's Gross Margin had its largest YoY gain of 217000bps in 2024, and its largest YoY loss of -50300bps in 2024.
  • Over the past 3 years, Profound Medical's Gross Margin (Quarter) stood at 49.23% in 2023, then skyrocketed by 44bps to 70.93% in 2024, then grew by 5bps to 74.32% in 2025.
  • Its Gross Margin was 74.32% in Q3 2025, compared to 73.18% in Q2 2025 and 70.7% in Q1 2025.